跳至主要内容
临床试验/EUCTR2010-018249-78-GB
EUCTR2010-018249-78-GB进行中(未招募)不适用

Small Particle Inhaled Steroids in Refractory Steroid-responsive Asthma - Small Particle Steroids in Asthma. V1

niversity of Nottingham0 个研究点开始时间: 2010年3月18日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Non-smokers with refractory asthma (ACQ score =1.5 or requirement for oral steroids =twice per year despite treatment with high dose inhaled steroid and treatment with, or unsuccessful trial of, a long acting beta-2 agonist or leukotriene antagonist).
  • Sputum eosinophil count >3%
  • A response to a 2 week trial of oral steroids, defined as a reduction in ACQ score by 0.5, an increase in FEV1 of 200ml, or either normalisation or a fall in exhaled NO of =25 ppb.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Poor compliance with usual asthma treatment
  • Pregnancy, inadequate contraception or lactation
  • Active smoking or smoking history of >10 pack-years
  • Clinical diagnosis of ABPA or significant bronchiectasis
  • Another significant, active, medical co-morbidity
  • Use of a medication which interacts with ciclesonide (ketoconazole, itraconazole, ritonavir, nelfinavir)

研究者

发起方
niversity of Nottingham

相似试验